Biotech Company Receives Application Approval from Chinese Food and Drug Administration
Beike Biotechnology Co., Ltd. has officially been accepted into the approval process for the Chinese Food and Drug Administration for the use of human umbilical cord derived mesenchymal stem cells for clinical translation and treatment of systemic lupus erythematosus. [Beike Biotechnology Co., Ltd. (PR Newswire Association LLC)]
BioTime Announces Issuance of 14 Patents in the Fields of Regenerative Medicine, and Cancer Diagnosis and Therapy
BioTime, Inc. announced the issuance of 14 new patents to BioTime and its subsidiary companies. The patents issued in Australia, Canada, China, Japan, and the United States, cover a wide range of core technologies foundational to BioTime’s businesses. [BioTime, Inc.]
NIH Awards Scripps Researchers $2.6 Million to Develop Stem Cell Lines
Scientists from the Florida campus of The Scripps Research Institute have been awarded a $2.6 million grant from the office of the director of the National Institutes of Health (NIH) to produce specialized stems cells. [Genetic Engineering & Biotechnology News]
New wallchart from our sponsor:
Mesenchymal Stem Cells (a Nature Reviews Molecular Cell Biology collaboration). Request your free copy.